Decheng Capital China Life Sciences USD Fund III, L.P.

Related Filers (6)

Other (1)

D
Monday, 4/30/2018
Exempt (Private) Offering
Show More

Ownership (16)

4
Monday, 1/22/2024
ALPINE IMMUNE SCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 11/14/2023
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13D/A
Tuesday, 9/27/2022
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
4
Tuesday, 9/27/2022
ALPINE IMMUNE SCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/30/2021
Cue Health Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/23/2021
Cue Health Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/21/2021
ALPINE IMMUNE SCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 9/21/2021
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13D/A
Tuesday, 12/8/2020
BeyondSpring Inc.: Major Shareholders
SC 13D/A
Monday, 8/3/2020
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13D
Monday, 7/27/2020
BeyondSpring Inc.: Major Shareholders
SC 13G/A
Monday, 2/10/2020
BeyondSpring Inc.: Major Shareholders
SC 13G
Monday, 12/23/2019
SCYNEXIS INC: Major Shareholders
SC 13G
Friday, 8/2/2019
BeyondSpring Inc.: Major Shareholders
SC 13D
Thursday, 1/24/2019
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
3
Wednesday, 1/23/2019
ALPINE IMMUNE SCIENCES, INC.: Initial statement of beneficial ownership of securities
Show More